Foundation Impact

To increase awareness about Sudden Unexpected Death in Epilepsy (SUDEP), The Mark Shaparin Foundation is:

  • Attending medical conferences as exhibitors and speaking directly with healthcare providers of all specialties including physicians, physician assistants, nurse practitioners, nurses, paramedics, and emergency medical technicians.

  • Creating high quality interactive continuing medication education activities related to Seizure First Aid and SUDEP for healthcare providers in all specialties.

  • Reaching out to medical schools and conducting lectures to medical students about SUDEP.

  • Generating social media and other advertising campaigns about SUDEP risk factors and prevention strategies.

  • Holding events, in partnership with community organizations and companies, that educate the public about SUDEP and honor Mark’s life.

Impact Timeline

November 2024

Dr. Naum Shaparin, Mark’s dad, presenting at the 13th Annual New York & New Jersey Pain Medicine Congress in November 2024.

December 2024

January 2025

  • We exhibited at the North American Neuromodulation Society Annual Meeting, where they spoke with 75+ attendees. Only about 10 had previous knowledge about SUDEP, however one of them thought SUDEP only happened after many years of uncontrolled seizures. The pain-trained neurologist was surprised to learn SUDEP can happen after just one seizure and committed to changing his practice to educating patients at the first visit.

February & March 2025

  • We successfully launched and wrapped our first social media campaign — The Escargot Challenge — with participation from our donors and advocates including members of the medical community.

  • The challenge culminated in an in-person event on March 22 at Wayside Cottage in Scarsdale, NY.

  • We hosted a table at The Kimball Cup AAU Diving, Purchase College in Purchase, New York.

April 2025

  • We exhibited at the American College of Physicians Internal Medicine Meeting from April 3-5 in New Orleans. Exhibiting at this meeting was made possible by a grant from Neurelis, a biotechnology company that develops innovative treatments for people living with epilepsy and other neurological conditions.

  • Approximately 300 physicians stopped by our booth, giving us the opportunity to educate primary care providers about SUDEP risk factors and prevention strategies.

May 2025

  • From May 2-4, we attended the New Jersey Academy of Family Physicians Annual Meeting in Atlantic City, where we met many providers who were unaware of SUDEP.

  • From May 16-17, we exhibited at the Delaware Academy of Family Physicians Annual Meeting in Lewes, Delaware.

  • From May 28-30, we attended the Epilepsy Therapies & Diagnostics Development XVIII Symposium (ETDD) in Leesburg, Virginia. We learned more about high-quality, specialized wearable and video seizure detection device, which are critical to monitoring seizures and preventing SUDEP.

  • We participated in a study at Boston Children’s Hospital and Harvard Medical School, where researchers are seeking to better understand the experiences of parents who have lost a child to SUDEP. The researchers are aiming to raise SUDEP awareness and revise clinical guidelines to save lives.

June 2025

July 2025

  • Exhibiting at the American Society of Pain & Neuroscience Annual Conference, from July 17-20

November 2025

  • Epilepsy Awareness Day Expo: November 10-13

December 2025

  • Attending Partners Against Mortality in Epilepsy & American Epilepsy Society Meeting: December 4-9